Technology News and Research

RSS

Richmond Hill Children's Clinic patients to have real-time access to PHRs at mypatientaccess.ca

Canadian Patient Access Inc. and Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical records (EMR) software and related services today announce that mypatientaccess.ca, Canada's first secure, interactive patient portal will soon be made available to parents of more than 10,000 pediatric patients treated at the Richmond Hill Children's Clinic (Richmond Hill, ON).

21 Sep 2010

Semantic Stimuli Response Measurement technology measures response of subconscious mind

The National Mental Health Association reports that over 65 million Americans suffer from some type of mental illness and that 1 in 5 people will experience some mental illness during their life. By 2020, mental illness is projected to be the leading cause of disease burden in North America, an obviously staggering problem with total costs to society running into the hundreds of billions every year.

21 Sep 2010

Amedica announces US Spine acquisition

Amedica Corporation (AC), a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has acquired US Spine, a privately held, well-known medical device company focused on the development and commercialization of advanced spinal implant systems.

21 Sep 2010

Health Canada issues license for IgX PLEX Celiac test kit

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, announced today that Health Canada has issued a medical device license for its automated IgX PLEX Celiac(TM) microarray test kit that runs on the Company's automated SQiDworks(TM) platform. The license allows the Company to market and sell the IgX PLEX Celiac product in Canada.

21 Sep 2010

immatics raises EUR53.8million in Series C financing round

immatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that it has raised EUR53.8million in a Series C financing round. The new funds will allow the Company to finance the ongoing development of immatics' existing pipeline of advanced therapeutic cancer vaccine candidates.

21 Sep 2010

New MTWA technology is integrated in Quinton Q-Stress cardiac stress systems

Cambridge Heart, Inc., a developer of noninvasive diagnostic tests for cardiac disease, today announced the launch of its Microvolt T-Wave Alternans (MTWA) technology as an integrated part of industry-leading cardiac stress test systems manufactured and distributed by Cardiac Science Corporation. The MTWA technology, which can predict a patient's risk of sudden cardiac arrest (SCA), is now being offered to new and existing users of Cardiac Science's Quinton Q-Stress cardiac stress systems.

21 Sep 2010

ImmunoGen commences clinical testing with SAR566658 anticancer compound

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen's product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and marked, sustained pipeline growth thereafter.

21 Sep 2010

Cardiac Science launches MTWA module with Quinton Q-Stress systems

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, today announced the launch of a Microvolt T-Wave Alternans (MTWA) module that integrates with its industry leading Quinton Q-Stress cardiac stress systems.

21 Sep 2010

Cook Medical sponsors sessions to reduce risk of CRBSI infections

At the 24th Annual Scientific Meeting of the Association for Vascular Access (AVA), Cook Medical continues its dedication to educating medical communities on advancements in procedures and technologies. Cook will sponsor two sessions that examine how to combine process and technology to reduce the risk of dangerous catheter-related bloodstream infections (CRBSIs).

21 Sep 2010

NextGen enters agreement with VHA to promote clinical, financial solutions to hospitals

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.

21 Sep 2010

ProtAffin presents impressive efficacy data for PA401 in COPD

ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today presents compelling preclinical data in chronic obstructive pulmonary disease (COPD) for its lead product PA401 at the European Respiratory Society Congress in Barcelona, Spain. This conference is the largest gathering of scientists and clinicians in the respiratory community in the world. The Oral Presentation will be made in the session "Pre-clinical models of airways disease".

21 Sep 2010

Nonin Medical launches new pulse oximetry products at ERS 2010 Annual Congress

Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, today introduced new pulse oximetry products, a new clinical guidebook and a new European sales, distribution and customer service center at the European Respiratory Society (ERS) 2010 Annual Congress in Barcelona, Spain.

21 Sep 2010

Wilshire Oncology Medical Group and US Oncology enter Comprehensive Strategic Alliance relationship

Wilshire Oncology Medical Group, Inc., a physician-owned, multi-specialty cancer and blood disease practice in Southern California, and US Oncology, Inc., the nation's leading integrated oncology company, today announced a new collaboration in Southern California to expand patient access to high-quality, advanced cancer care through the United Network of US Oncology.

21 Sep 2010

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.

21 Sep 2010

Researchers discover new drug to control acute and chronic pain

American and Italian researchers have found that a novel drug allows anandamide a marijuana like chemical in the body to effectively control pain at the site of an injury.

21 Sep 2010

Enzo Biochem streamlines operations, expects gross margin improvements

Enzo Biochem, Inc., announced today that it has streamlined its operations, which is anticipated to result in a reduction in annualized operating expenses of more than $4 million beginning in the fiscal 2011 first quarter. These initiatives are also expected to result in increased gross margins. The Company believes that the operating cost reductions, which affect all of its operating businesses as well as corporate overhead, will result in Enzo generating positive cash flow from operations in 2011.

21 Sep 2010

Cook Medical expands Spectrum Turbo-Ject line of antibiotic impregnated PICCs for CRBSIs

Responding to increased demand for technology to help prevent potentially fatal catheter-related bloodstream infections (CRBSIs), Cook Medical has expanded its Spectrum Turbo-Ject line of antibiotic impregnated peripherally inserted central venous catheters (PICCs) to treat a wider range of patient needs. For the first time, the clinical benefits of minocycline and rifampin-impregnated PICCs, a critical component in eliminating 250,000 potentially fatal CRBSIs in the U.S. annually, are now available in 3 French single and 6 French triple lumen sizes.

21 Sep 2010

FDA accepts IND application for vaccine candidate based on iBioLaunch technology platform

iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.

21 Sep 2010

U.N. MDG summit begins; UNAIDS data shows 22 African countries see drop in new HIV infections

"Ten years after world leaders set the most ambitious goals ever to tackle global poverty, they are meeting again to try to spur action to meet the targets by the 2015 deadline - which the U.N. says will be difficult, if not impossible, in some cases," the Associated Press reports. More than 140 world leaders are scheduled to participate in the three-day U.N. Summit on the Millennium Development Goals (MDGs), which kicks off Monday.

21 Sep 2010

Arrayit installs microarray platform at NIH

Arrayit Corporation has completed installation and technical training of its proprietary microarray platform at the National Institute of Mental Health, National Institutes of Health, in Rockville, Maryland. In 2010, the NIH will invest more than $31.2 billion in medical research for the American people through 50,000 competitive grants to 325,000 researchers at 3,000 universities, hospitals, companies, medical schools and scientific institutions in the United States and around the world.

21 Sep 2010

Technology News and Research

Richmond Hill Children's Clinic patients to have real-time access to PHRs at mypatientaccess.ca

Semantic Stimuli Response Measurement technology measures response of subconscious mind

Amedica announces US Spine acquisition

Health Canada issues license for IgX PLEX Celiac test kit

immatics raises EUR53.8million in Series C financing round

New MTWA technology is integrated in Quinton Q-Stress cardiac stress systems

ImmunoGen commences clinical testing with SAR566658 anticancer compound

Cardiac Science launches MTWA module with Quinton Q-Stress systems

Cook Medical sponsors sessions to reduce risk of CRBSI infections

NextGen enters agreement with VHA to promote clinical, financial solutions to hospitals

ProtAffin presents impressive efficacy data for PA401 in COPD

Nonin Medical launches new pulse oximetry products at ERS 2010 Annual Congress

Wilshire Oncology Medical Group and US Oncology enter Comprehensive Strategic Alliance relationship

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

Researchers discover new drug to control acute and chronic pain

Enzo Biochem streamlines operations, expects gross margin improvements

Cook Medical expands Spectrum Turbo-Ject line of antibiotic impregnated PICCs for CRBSIs

FDA accepts IND application for vaccine candidate based on iBioLaunch technology platform

U.N. MDG summit begins; UNAIDS data shows 22 African countries see drop in new HIV infections

Arrayit installs microarray platform at NIH

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News